Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance

Acta Neurochirurgica

Volumn 147, Issue 7, 2005, Pages 751-757

  Delgrange, E ^a   Sassolas, G ^b   Perrin, G ^b   Jan, M ^c   Trouillas, J ^d  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b HÔPITAL NEUROLOGIQUE   (France)

^c UNIVERSITY HOSPITAL OF TOURS   (France)

^d INSERM   (France)

Author keywords

Dopamine agonist resistance; Ki 67; Mitotic activity; Neurosurgery; Pituitary; Prolactinoma

Indexed keywords

BROMOCRIPTINE; CYCLINE; KI 67 ANTIGEN; PROLACTIN;

AGE DISTRIBUTION; ARTICLE; BONE METASTASIS; CANCER INVASION; CANCER STAGING; CAVERNOUS SINUS; CELL STRUCTURE; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MALE; MITOSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; SEX DIFFERENCE; TRANSSPHENOIDAL SURGERY; TUMOR VOLUME;

EID: 20744456570     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-005-0498-2     Document Type: Article

References (18)

1. Brue T, Pellegrini I, Priou A, Morange I, Jaquet P (1992) Prolactinomas and resistance to dopamine agonists. Horm Res 38: 84-89
2. Calle-Rodrigue RDP, Giannini C, Scheithauer BW, Lloyd RV, Wollan PC, Kovacs KT, Stefaneanu L, Ebright AB, Abboud CF, Davis DH (1998) Prolactinomas in male and female patients: a comparative clinicopathologic study. Mayo Clin Proc 73: 1046-1052
3. Cottier JP, Destrieux C, Brunereau L, Bertrand P, Moreau L, Jan M, Herbreteau D (2000) Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology 215: 463-469
4. Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J (1997) Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 82: 2102-2107
5. Jaffrain-Rea ML, Di Stefano D, Minniti G, Esposito V, Bultrini A, Ferretti E, Santoro A, Faticanti Scucchi L, Gulino A, Cantore G (2002) A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas. Endocr Relat Cancer 9: 103-113
6. Jefferson G (1940) Extrasellar extensions of pituitary adenomas. Proc R S Med 33: 433-458
7. Kovacs K, Stefaneanu L, Horwath E, Buchfelder M, Fahlbusch R, Becker W (1995) Prolactin- producing pituitary tumor: resistance to dopamine agonist therapy. J Neurosurg 82: 886-890
8. Medeiros LJ, Weiss LM (1992) New developments in the pathologic diagnosis of adrenal cortical neoplasms. Am J Clin Pathol 97: 73-83
9. Pernicone PJ, Scheithauer BW, Sebo TJ, Kovacs KT, Horvath E, Young WF, Lloyd RV, Davis DH, Guthrie BL, Schoene WC (1997) Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 79: 804-812
10. Perrin G, Treluyer C, Trouillas J, Sassolas G, Goutelle A (1991) Surgical outcome and pathological effects of bromocriptine pre-operative treatment in prolactinomas. Path Res Pract 187: 587-592
11. Qian ZR, Li CC, Yamasaki H, Mizusawa N, Yoshimoto K, Yamada S, Tashiro T, Horiguchi H, Wakatsuki S, Hirokawa M, Sano T (2002) Role of E-Cadherin, alpha-, beta-, and gamma-Catenins, and p120 (Cell Adhesion Molecules) in prolactinoma behavior. Mod Pathol 15: 1357-1365
12. Robert F (1983) Morphology of human prolactinomas: a study on invasive prolactin-secreting adenomas. In: Tolis G (ed) Prolactin and prolactinomas. Raven Press, New York, pp 339-349
13. Schreiber S, Saeger W, Lüdecke DK (1999) Proliferation markers in different types of clinically non-secreting pituitary adenomas. Pituitary 1: 213-220
14. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws ER (1996) Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MTB-1 antibody. Neurosurgery 38: 99-107
15. Trouillas J, Girod C (1996) Pathology of pituitary adenomas. In: Landolt AM, Vance ML, Reilly PL (eds) Pituitary adenomas. Churchill Livingstone Publishers, New York, pp 27-46
16. Trouillas J, Chevallier P, Remy C, Rajas F, Cohen R, Calle A, Hooghe-Peters EL, Rousset B (1999) Differential actions of dopamine agonist bromocriptine on growth of SM TW tumors exhibiting a prolactin and/or a somatotroph cell phenotype: relation to dopamine D2 receptor expression. Endocrinology 140: 13-21
17. Trouillas J, Daniel L, Guigard MP, Tong S, Gouvernet J, Jouanneau E, Jan M, Perrin G, Fischer G, Tabarin A, Rougon G, Figarella-Branger D (2003) Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion. J Neurosurg 98: 1084-1093
18. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JAH (2000) Angiogenesis in pituitary adenomas and the normal pituitary. J Clin Endocrinol Metab 85: 1159-1162